FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081295 [Registered on: 25/02/2025] Trial Registered Prospectively
Last Modified On: 19/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Development of an automated Portable Parisheka device and its comparative efficacy with traditional Parisheka using Dashamoola Kashaya in the management of Amavata (Rheumatoid Arthritis) 
Scientific Title of Study   Development of an automated portable Parisheka device and a comparative study of its efficacy with traditional Parisheka using Dashamoola Kashaya in Amavata (Rheumatoid Arthritis) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr ARUN N K 
Designation  PhD Scholar 
Affiliation  All India Institute of Ayurveda New Delhi 
Address  Department of Panchakarma 7th Floor Academic block, All India Institute of Ayurveda Gautampuri Awas Sarita Vihar New Delhi India

South
DELHI
110076
India 
Phone  9061180158  
Fax    
Email  arunnarayan.nk@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr PRASANTH DHARMARAJAN 
Designation  Associate Professor 
Affiliation  All India Institute of Ayurveda New Delhi 
Address  Department of Panchakarma 7th Floor Academic block All India Institute of Ayurveda Gautampuri awas Sarita vihar New Delhi

South
DELHI
110076
India 
Phone  9895174060  
Fax    
Email  drprasanthd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr ARUN N K 
Designation  PhD Scholar 
Affiliation  All India Institute of Ayurveda New Delhi 
Address  Department of Panchakarma 7th Floor Academic block, All India Institute of Ayurveda Gautampuri Awas Sarita Vihar New Delhi India

South
DELHI
110076
India 
Phone  9061180158  
Fax    
Email  arunnarayan.nk@gmail.com  
 
Source of Monetary or Material Support  
Scholar and All India Institute of Ayurveda, Sarita Vihar, South Delhi, 110076 India 
 
Primary Sponsor  
Name  All India Institute of Ayurveda 
Address  NH19, Gautampuri Awas, Sarita Vihar, New Delhi, India 110076 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Arun NK  All India Institute of Ayurveda New Delhi  OPD Number 6, Ground floor, Hospital block, All India Institute of Ayurveda New Delhi. Sarita vihar 110076
South
DELHI 
9061180158

arunnarayan.nk@gmail.com  
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Division of Translational Research and Biostatistics  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M058||Other rheumatoid arthritis with rheumatoid factor. Ayurveda Condition: AMAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-pariSheka, परिषेक (Procedure Reference: Ashtanga Hridayam, Procedure details: Continues pouring of luke warm dashamoola kashaya through body with the help of developed automated portable parisheka device for the duration of 40 to 45 minutes)
(1) Medicine Name: Dashamoola Kashayam, Reference: Ashtanga Hridayam Sutrasthana, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 4000(ml), Frequency: od, Duration: 7 Days
2Comparator ArmProcedure-pariSheka, परिषेक (Procedure Reference: Ashtanga Hridayam Sutrasthana, Procedure details: Continues pouring of luke warm dashamoola kashaya through body with classical method for the duration of 40 to 45 minutes )
(1) Medicine Name: Dashamoola Kashaya, Reference: Ashtanga Hridayam Suthrasthana, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 4000(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients aged 20 to 60 years, irrespective of gender, presenting with clinical features of Amavata with Paithika characteristics such as Daha and Raga as described in Ayurvedic classics, and having a confirmed diagnosis of Rheumatoid Arthritis fulfilling the EULAR 2010 criteria, will be included. The study will consider RA patients with tenderness and chronicity of less than 5 years or those who are freshly diagnosed. Eligible participants must be suitable for Swedana procedures and should not have taken NSAIDs or short-acting steroids for the past 1–2 weeks. Additionally, patients must be willing to provide informed consent and adhere to the study protocol 
 
ExclusionCriteria 
Details  Exclusion criteria include patients suffering from paralysis affecting motor function, diagnosed cases of neoplasm of the spine, gout, traumatic arthritis, or pyogenic osteomyelitis. Patients with comorbidities such as cardiac disease, pulmonary tuberculosis, uncontrolled diabetes mellitus, inflammatory bowel disease, malignant hypertension, or renal function impairment, as well as pregnant women and lactating mothers, will not be included. Individuals contraindicated for Swedana procedures or those with severe peripheral artery disease or other significant vascular conditions that could be worsened by Parisheka therapy are also excluded 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in pain scores (VAS) and Reduction in inflammatory markers (CRP, ESR) and achievement of Samyak Swedana Lakshana
 
0 days, 8 days or 15 days or 22 days
 
 
Secondary Outcome  
Outcome  TimePoints 
• Patient’s and Administrator’s responses, Dermalab parameters during Parisheka using the automated portable device versus the traditional method.   0 days, 8 days or 15 days or 22 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

RESEARCH QUESTION

Does the development of an automated portable Parisheka device improve the efficiency in the administration of Dashamoola Kashaya Parisheka procedure and its effectiveness of pain management in Amavata compared to the traditional method of Parisheka?

HYPOTHESIS

Automated portable Parisheka device will be more efficient in the administration of Dasamoola Kashaya Parisheka procedure and more effective in the management of pain in Amavata compared to the traditional method of Parisheka

Null Hypothesis (Ho):

There is no difference in the efficiency of Dashamoola Kashaya Parisheka and its effectiveness in the management of pain in Amavata when done with automated portable Parisheka device compared to the traditional Parisheka procedure.

Alternative Hypothesis (H1):

The developed automated portable Parisheka device has superior efficiency in the administration of Dashamoola Kashaya Parisheka and is more effective in the management of pain in Amavata compared to the traditional Parisheka procedure.

AIM

Develop an automated portable Parisheka device and evaluate its efficacy compared to that of traditional Parisheka procedure in Amavata

OBJECTIVES:

Ø  Primary Objective:

1.     To develop an automated portable Parisheka device that is capable of administering Parisheka effectively and uniformly.

Ø  Secondary Objective:

1.     To check the Patient’s and Administrator’s responses during Parisheka procedure with   automated portable Parisheka device and with current traditional method.

2.     To evaluate and compare the efficacy of the automated portable Parisheka device with the traditional Parisheka method in Amavata (Rheumatoid Arthritis) by using Dashamoola Kashaya Parisheka and Pachana medicine.

3.     To compare the changes in following parameters of Dermalab instrument before and after Dashamoola Kashaya Parisheka and Pachana medicine.

Ø  Skin pH         

Ø  Skin sebum

Ø  Skin hydration          

Ø  Skin color

Ø  TEWL Video microscopy

Ø  Skin Elasticity

Ø  Temperature

4.     To compare the changes in the following parameters before and after Dashamoola Kashaya Parisheka with Pachana medicine and compare it within 2groups.

A.    Inflammatory markers ie., CRP, ESR

B.     Samyak Swedan lakshana assessment.

C.    Pain assessment with Visual Analoge Score

PLAN OF STUDY

The study will be carried out in the following phases

1.     Survey study

2.     Device Designing and Development

3.     Validation

4.     Clinical study


 
Close